144 related articles for article (PubMed ID: 15222690)
21. The impact of our genes: consequences of the apolipoprotein E polymorphism in Alzheimer disease and multiple sclerosis.
Fazekas F; Enzinger C; Ropele S; Schmidt H; Schmidt R; Strasser-Fuchs S
J Neurol Sci; 2006 Jun; 245(1-2):35-9. PubMed ID: 16631796
[TBL] [Abstract][Full Text] [Related]
22. Apolipoprotein E genotype related differences in brain lesions of multiple sclerosis.
Fazekas F; Strasser-Fuchs S; Schmidt H; Enzinger C; Ropele S; Lechner A; Flooh E; Schmidt R; Hartung HP
J Neurol Neurosurg Psychiatry; 2000 Jul; 69(1):25-8. PubMed ID: 10864599
[TBL] [Abstract][Full Text] [Related]
23. ApolipoproteinE epsilon 4 allele is not associated with disease course and severity in multiple sclerosis.
Portaccio E; Zipoli V; Goretti B; Hakiki B; Nacmias B; Siracusa G; Sorbi S; Amato MP
Acta Neurol Scand; 2009 Dec; 120(6):439-41. PubMed ID: 19804477
[TBL] [Abstract][Full Text] [Related]
24. Preliminary observations on APOE epsilon4 allele and progression of disability in multiple sclerosis.
Chapman J; Sylantiev C; Nisipeanu P; Korczyn AD
Arch Neurol; 1999 Dec; 56(12):1484-7. PubMed ID: 10593303
[TBL] [Abstract][Full Text] [Related]
25. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
[TBL] [Abstract][Full Text] [Related]
26. Apolipoprotein E polymorphism interacts with cigarette smoking in progression of multiple sclerosis.
Sena A; Couderc R; Ferret-Sena V; Pedrosa R; Andrade ML; Araujo C; Roque R; Cascais MJ; Morais MG
Eur J Neurol; 2009 Jul; 16(7):832-7. PubMed ID: 19473356
[TBL] [Abstract][Full Text] [Related]
27. Association of apolipoprotein E epsilon2 with white matter disease but not with microbleeds.
Lemmens R; Görner A; Schrooten M; Thijs V
Stroke; 2007 Apr; 38(4):1185-8. PubMed ID: 17322072
[TBL] [Abstract][Full Text] [Related]
28. [The absence of a relation between apolipoprotein E genotypes and the severity of multiple sclerosis in Mexican patients].
Corona T; Guerrero-Camacho JL; Alonso-Vilatela ME; Flores-Rivera Jde J
Rev Neurol; 2010 Jan 1-15; 50(1):19-22. PubMed ID: 20073019
[TBL] [Abstract][Full Text] [Related]
29. Cognitive impairment in patients with multiple sclerosis: association with the APOE gene and promoter polymorphisms.
Parmenter BA; Denney DR; Lynch SG; Middleton LS; Harlan LM
Mult Scler; 2007 Jan; 13(1):25-32. PubMed ID: 17294608
[TBL] [Abstract][Full Text] [Related]
30. Association of APOE polymorphisms with disease severity in MS is limited to women.
Kantarci OH; Hebrink DD; Achenbach SJ; Pittock SJ; Altintas A; Schaefer-Klein JL; Atkinson EJ; De Andrade M; McMurray CT; Rodriguez M; Weinshenker BG
Neurology; 2004 Mar; 62(5):811-4. PubMed ID: 15007140
[TBL] [Abstract][Full Text] [Related]
31. Lower levels of N-acetylaspartate in multiple sclerosis patients with the apolipoprotein E epsilon4 allele.
Enzinger C; Ropele S; Strasser-Fuchs S; Kapeller P; Schmidt H; Poltrum B; Schmidt R; Hartung HP; Fazekas F
Arch Neurol; 2003 Jan; 60(1):65-70. PubMed ID: 12533090
[TBL] [Abstract][Full Text] [Related]
32. Apolipoprotein E genotype in Korean schizophrenic patients.
Lee MK; Park AJ; Nam BY; Min KJ; Kee BS; Park DB
J Korean Med Sci; 2001 Dec; 16(6):781-3. PubMed ID: 11748362
[TBL] [Abstract][Full Text] [Related]
33. Polymorphisms of apolipoprotein E and Japanese patients with multiple sclerosis.
Niino M; Kikuchi S; Fukazawa T; Yabe I; Tashiro K
Mult Scler; 2003 Aug; 9(4):382-6. PubMed ID: 12926843
[TBL] [Abstract][Full Text] [Related]
34. ApoE alleles, depression and positive affect in multiple sclerosis.
Julian LJ; Vella L; Frankel D; Minden SL; Oksenberg JR; Mohr DC
Mult Scler; 2009 Mar; 15(3):311-5. PubMed ID: 19244396
[TBL] [Abstract][Full Text] [Related]
35. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
36. The association of apolipoprotein E (APOE) gene polymorphisms with atherosclerosis susceptibility: a meta-analysis.
Zhu H; Xue H; Wang H; Ma Y; Liu J; Chen Y
Minerva Cardioangiol; 2016 Feb; 64(1):47-54. PubMed ID: 26005211
[TBL] [Abstract][Full Text] [Related]
37. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
Vaisi-Raygani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
Clin Biochem; 2007 Oct; 40(15):1150-6. PubMed ID: 17689519
[TBL] [Abstract][Full Text] [Related]
38. No association between APOE ε 4 allele and multiple sclerosis susceptibility: a meta-analysis from 5472 cases and 4727 controls.
Xuan C; Zhang BB; Li M; Deng KF; Yang T; Zhang XE
J Neurol Sci; 2011 Sep; 308(1-2):110-6. PubMed ID: 21679970
[TBL] [Abstract][Full Text] [Related]
39. APOE genotypes in African American female multiple sclerosis patients.
Huang R; Hughes M; Mobley S; Lanham I; Poduslo SE
Neurosci Lett; 2007 Feb; 414(1):51-6. PubMed ID: 17254710
[TBL] [Abstract][Full Text] [Related]
40. Accelerated evolution of brain atrophy and "black holes" in MS patients with APOE-epsilon 4.
Enzinger C; Ropele S; Smith S; Strasser-Fuchs S; Poltrum B; Schmidt H; Matthews PM; Fazekas F
Ann Neurol; 2004 Apr; 55(4):563-9. PubMed ID: 15048896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
